12:00 AM
 | 
Jan 14, 2013
 |  BC Week In Review  |  Company News  |  Deals

Intrexon, Sanford-Burnham Medical Research Institute deal

Intrexon granted the institute rights to use Intrexon's cellular selection and gene regulation technologies for human induced pluripotent stem cell (iPSC) research. The...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >